Heart Failure Clinical Trial
A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure
Summary
The aim of this study was to determine whether long-term (≥ 6 months at the target dose) blockade of ETA receptors using sitaxsentan showed functional benefit in subjects with chronic Heart Failure and an Left Ventricular Ejection Fraction ≥50%.
Eligibility Criteria
Inclusion Criteria:
18 or older with chronic heart failure and evidence of diastolic dysfunction on echocardiogram, heart imaging, and a minimum exercise tolerance average time of 120 seconds on two treadmill tests within 2 weeks of enrollment
Exclusion Criteria:
unstable cardiovascular disease within 4 weeks of screening, history of heart attack, cardiac by-pass surgery or percutaneous intervention, stent placement, within 3 months of screening or amyloidosis, hypertrophic obstructive or restrictive cardiomyopathy, or constrictive pericarditis
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 46 Locations for this study
Birmingham Alabama, 35294, United States
Mobile Alabama, 36608, United States
Mobile Alabama, 36608, United States
Little Rock Alaska, 72205, United States
Phoenix Arizona, 85013, United States
Tucson Arizona, 85715, United States
Tucson Arizona, 85715, United States
Little Rock Arkansas, 72205, United States
Los Angeles California, 90033, United States
Orange California, 92868, United States
Sacramento California, 95825, United States
San Diego California, 92103, United States
New Haven Connecticut, 06510, United States
Washington District of Columbia, 20011, United States
Orlando Florida, 32803, United States
Chicago Illinois, 60637, United States
Peoria Illinois, 61606, United States
Auburn Maine, 04210, United States
Boston Massachusetts, 02114, United States
Boston Massachusetts, 02115, United States
Minneapolis Minnesota, 55417, United States
Saint Louis Missouri, 63110, United States
Saint Louis Missouri, 63110, United States
Lincoln Nebraska, 68526, United States
Manchester New Hampshire, 03102, United States
Newark New Jersey, 07112, United States
Buffalo New York, 14221, United States
New York New York, 10032, United States
Troy New York, 11218, United States
Charlotte North Carolina, 28204, United States
Huntersville North Carolina, 28078, United States
Winston-Salem North Carolina, 27157, United States
Columbus Ohio, 43210, United States
Oklahoma City Oklahoma, 73120, United States
Portland Oregon, 97220, United States
Philadelphia Pennsylvania, 19104, United States
Philadelphia Pennsylvania, 19140, United States
Philadelphia Pennsylvania, 19141, United States
Pittsburgh Pennsylvania, 15212, United States
Charleston South Carolina, 29401, United States
Rapid City South Dakota, 57701, United States
Germantown Tennessee, 38138, United States
Houston Texas, 77030, United States
Houston Texas, 77030, United States
Houston Texas, 77030, United States
Murray Utah, 84157, United States
Salt Lake City Utah, 84132, United States
Burlington Vermont, 05401, United States
Richmond Virginia, 23298, United States
Madison Wisconsin, 53792, United States
Toronto Ontario, M5B1W, Canada
Montreal Quebec, H3T 1, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.